key: cord-0827186-tae8vcnm
authors: Hamza, Muhammad; Ali, Ashaq; Khan, Suliman; Ahmed, Saeed; Attique, Zarlish; Ur Rehman, Saad; Khan, Ayesha; Ali, Hussain; Rizwan, Muhammad; Munir, Anum; Khan, Arshad Mehmood; Siddique, Faiza; Mehmood, Azhar; Nouroz, Faisal; Khan, Sajid
title: nCOV-19 peptides mass fingerprinting identification, binding, and blocking of inhibitors flavonoids and anthraquinone of Moringa oleifera and hydroxychloroquine
date: 2020-06-22
journal: J Biomol Struct Dyn
DOI: 10.1080/07391102.2020.1778534
sha: 19a19dcc5b8207923d9b5d33790588bfd1eaf47a
doc_id: 827186
cord_uid: tae8vcnm

An rare pandemic of viral pneumonia occurs in December 2019 in Wuhan, China, which is now recognized internationally as Corona Virus Disease 2019 (COVID-19), the etiological agent classified as Severe Acute Respiratory Syndrome Corona Virus 2 (SARS-CoV-2). According to the World Health Organization (WHO), it has so far expanded to more than 213 countries/territories worldwide. Our study aims to find the viral peptides of SARS-COV-2 by peptide mass fingerprinting (PMF) in order to predict its novel structure and find an inhibitor for each viral peptide. For this reason, we calculated the mass of amino acid sequences translated from the SARS-CoV2 whole genome and identify the peptides that may be a target for inhibition. Molecular peptide docking with Moringa oleifera, phytochemicals (aqueous and ethanolic) leaf extracts of flavonoids (3.56 ± 0.03), (3.83 ± 0.02), anthraquinone (11.68 ± 0.04), (10.86 ± 0.06) and hydroxychloroquine present therapy of COVID-19 in Pakistan for comparative study. Results indicate that 15 peptides of SARS-CoV2 have been identified from PMF, which is then used as a selective inhibitor. The maximum energy obtained from AutoDock Vina for hydroxychloroquine is –5.1 kcal/mol, kaempferol (flavonoid) is –6.2 kcal/mol, and for anthraquinone –6 kcal/mol. Visualization of docking complex, important effects are observed regarding the binding of peptides to drug compounds. In conclusion, it is proposed that these compounds are effective antiviral agents against COVID-19 and can be used in clinical trials. Communicated by Ramaswamy H. Sarma

Identified cases of trigger pneumonia were recorded in Wuhan City by the Health Commission of Hubei province, China, in December 2019, having clinical manifestation with viral pneumonia. (Chan et al., 2020; Chen et al., 2020; Kumar, 2020; Lu et al., 2020; Tahir Ul Qamar et al., 2019; Umesh et al., 2020) . Initially, 27 patients were registered, and the number increased to 41 on 11 January 2020 (Chan et al., 2020) . Finally, World Health Organization (WHO) declared it as Corona Viruses Disease 2019 . As of April 21, 2020 about 250,000 Laboratory confirmed cases have been identified worldwide. Of these, 170,000 died (Fahmi, 2020) . As data compiled by the WHO, some of the worst-affected nations such as China in the western Pacific, have 84,237 confirmed cases with 4,642 deaths. The situation in the European region worsens with 195,944 cases in Spain, Islam et al., 2020; Tahir Ul Qamar et al., 2019; Wahedi et al., 2020) . This renders 74.5% of the genome equivalent to SARS-CoV .

The third most virulent disease of the 21st century triggered by the MERS-COV and SARS-COV has a significant fatality rate (Khan, Zia, et al., 2020) . Coronavirus is a nonsegmented, enveloped, positive-stranded RNA virus with an RNA genome that ranging 26 to 32 kb in length Sinha et al., 2020; Wu et al., 2020) . The coronae family has four main genetic subgroups, namely alpha coronavirus genus, beta coronavirus genus, delta coronavirus genus, and gamma coronavirus genus. There are several types of human coronavirus, particularly, HCoV-HKU1, HCoV-229E, HCoV-NL63, and HCoV-OC43 which flow into the human body and induce lenient respiratory infection (Enayatkhani et al., 2020) . Since in the epidemic of SARS-COV in 2002 MERS-CoV in 2012 identified extremely pathogenic properties of human coronavirus causing extreme respiratory syndrome accumulating 10,000 cases over the last two decades with a 10% death rate for SARS-CoV and 37% for MERS-CoV (Elfiky & Azzam, 2020) . SAR-COV-2 is spread via the respiratory tract and therefore causes pneumonia; thus, a molecular diagnosis with oral swabs had been provided for the approval of this disease. It may also be spread by infected intestines via oral fecal route (Khan, Jha, et al., 2020; Zhang et al., 2020) .

The Structure of SARS-CoV-2 consists of three major viral proteins namely Spike protein (S) that causes viral infection by binding to the host receptor. A Membrane protein (M) and envelope protein (E) (Abdelli et al., 2020; Boopathi et al., 2020; Sarma et al., 2020; Wahedi et al., 2020) .

ACE2 is the essential receptor that interacts with spike protein on the host cell membrane (Hasan et al., 2020) . The common signs and symptoms of coronavirus include, fever, trouble coughing, difficulty in breathing, pyrexia, potentially lethal pneumonia, more severe types of kidney failure, fatigue, diarrhea, rhinorrhea, vomiting, and nausea. Senior citizens are prone to be infected by this disease Gyebi et al., 2020; Kumar et al., 2020; Lobo-galo et al., 2020) .

In this study, the peptide mass fingerprinting (PMF) technique was conducted on SARS-CoV-2. Peptide mass fingerprinting is one of the significant methods used to identify peptides, especially through the deployment of molecular masses of peptides. PMF is chosen on the basis of simple and most effective process for the detection of peptides with specific masses and is one of the key technologies driving the growth of proteomics (Henzel et al., 2003) . In this technique, first, the protein of interest is digested into small fragments called peptide with the aid of endonucleases typically trypsin owing to its satisfactory and magnificent characteristics (Matthiesen, 2013) . Second, the mass spectroscopy analysis is performed to test the precise mass of the peptides, and this step gives the catalog of the peak inventory of such identified peptides. Third, this number of peak list associated with the abstract number of peaks obtained by in-silico digestion using various databases. Then the computer software identifies the protein by creating the leading match for it. One of the key advantages of the PMF is that it does not rely on protein sequencing for protein identification, and is very simple to do (Liebler, 2016) .

Medicinal plants are commonly used for the treatment of bacterial and noninfectious diseases and disorders. Emerging infectious diseases present a relentless danger to human life (Aanouz et al., 2020; Shinwari et al., 2020) . So, we selected a medicinal plant and a drug to check its activity against COVID-19. The medicinal plant, Moringa oleifera is extremely nutritional and serves as an antiretroviral lead molecule to improve the activity of immune-system with antipyretic, antiulcer, antispasmodic, antiulcer, antibacterial, antioxidant, antihypertensive, cardiac, and circulatory analeptic properties. Moringa oleifera is often known to be a "Miracle Tree" because of its strong immune-boosting and antimicrobial characteristics categorize in the family of Moringacae (Busani et al., 2011; Kini et al., 2017) . By phytochemical screening and extraction of M. oleifera shows the presence of alkaloids, saponins, tannins, glycosides, carbohydrates, flavonoids, resins, acidic compounds and proteins in various parts of plant in specific, seeds, leaves, fruits, flowers, barks, and unripe pods (Kini et al., 2017; Shinwari et al., 2020) . Flavonoids often have an inhibitory effect against viruses, especially a respiratory syncytial virus (Das et al., 2020) . Many of the works reveals that M. oleifera derived gist inhibits initiation of the viral replication cycle (Shinwari et al., 2020) . The presence of phytochemical Anthraquinone in Moringa oleifera extract serves as an antiviral and antifungal agent to rehabilitate minor diseases found in many plants (Kasolo et al., 2010) . This compound exhibits the antiviral properties towards the human cytomegalovirus HCMV strain and displays the inhibitory effects against the polioviruses. It also indicate a strong degree of antiviral activity towards HIV-1 ( Barnard et al., 1992; Schinazi et al., 1990; Semple et al., 2001) . In Moringa oleifera, both the ethanolic and aqueous extracts are rich in flavonoids (3.83 ± 0.02), (3.56 ± 0.03), and anthraquinone (10.86 ± 0.06), (11.68 ± 0.04) respectively (Nkechinyere Onyekwere & Felix, 2014) . Moringa oleifera is chosen due to these essential antiviral components which have demonstrated significant antiviral activity against viral diseases. Though the hydroxychloroquine HCQ a derivative of Chloroquine prescribed for the treatment of autoimmune diseases and anti-inflammatory agents is virulent than chloroquine. HCQ is also included in the triallist to treat COVID-19 Wang et al., 2020) . There is theoretical, experimental, preclinical, and clinical evidence of the effectiveness of hydroxychloroquine in patients affected with COVID-19. The hydroxychloroquine works by suppressing lysosomes and reducing various cell functions of immune cells that's why it is used in rheumatologic conditions and its anti-inflammatory effects. Many in vitro studies confirm that hydroxychloroquine is more potent in inhibiting SARS CoV-2 (Schrezenmeier & D€ orner, 2020; Yao et al., 2020) .

In computer-aided drug designing and structural molecular biology, a key tool in molecular docking. It aims to identify the major binding modes of a ligand. Docking is important for broader libraries of compounds for virtual screening (Barnard et al., 1992; Elmezayen et al., 2020; Muralidharan et al., 2020) . AutoDock Vina is an effective, readily available molecular docking technique that is recognized for its successful usage in research analysis and drug discovery (Forli et al., 2016) . It is considered as a standardized system that uses a highly structured method from its local optimization from its local optimization mechanism with a single assessment (Trott and Olson, 2010) . It acquires systematize files for ligand and receptor, then test and offers optimal dock conformities with well-tested default procedures. This is commonly used in various aspects, primarily virtual screening (Forli et al., 2016) .

In our study, by using the mass fingerprinting technique, we use Moringa oleifera as an effective inhibitor against nCOV-2019. The extract of this medicinal plant will improve the immune system to produce antibodies against SARS-COV-2 ( Figure 1 ).

The whole genome sequence of novel coronavirus was obtained through NCBI (https://www.ncbi.nlm.nih.gov/) with accession no: MN908947.3, 29,903bp in length and described as severe acute respiratory syndrome coronavirus 2 originated from Wuhan-Hu-1 on 18 March 2020 (Kruse, 2020).

The obtained sequence of SARS-COV-2 was translated into protein for the identification of peptides. The translation was done by EMBL EMBOSS TRANSEQ (http://www.ebi.ac.uk). It translates the nucleotide sequence into an amino acid sequence. It gives three forward and three reverse frames. This may also result in multiple outputs at once (Rice et al., 2000) .

The protein sequence was digested by Protein Prospector (Baker et al., 2008) , and the mass of peptide was calculated from Online Bioinformatics Tool PeptideMass (http://web. expasy.org/peptide_mass/). The purpose of PeptideMass tool is to help peptide-mapping experiments, culminating in the analysis of peptide-mass fingerprinting (PMF) and mass-spectrometry data (Wilkins et al., 1999) . Trypsin was used to cut the protein sequence in order to estimate the number of peptide masses and mass to charge ratio of protein (Gundry et al., 2010) . The peak list of peptides was generated by mass to charge ratio of protein from protein mass calculations. 

The homology modeling of the identified peak list was conducted by the Mascot server (Tsugita et al., 2000) . This server determines the active peptides by comparing the calculated peak lists with already existing masses of peptides in the database, resulting in the active peptides with additional information.

The peptides structures were predicted through the PEP-FOLD3 server, which is a de novo approach for peptide prediction. It predicts the structure of peptides having a sequence between 5 and 50 amino acids. PEP-FOLD3 is quicker and gives results in a few minutes (Lamiable et al., 2016) .

The selected active peptides of SARS-COV2 were docked with selected three antiviral activity containing compounds, to check their efficacy against SARS-CoV-2. Flavonoids and Anthraquinone are the phytochemical extracts of Moringa oleifera, which contain antiviral properties (Shinwari et al., 2020) , and hydroxychloroquine which is the derivative of chloroquine and is used to treat autoimmune diseases ). The compounds were tested for Lipinski rule of 5 by ACD/I Lab, while their toxicity was checked by the protox server (Drwal et al., 2014; Masunov, 2001 ).

Resultant Docked Complexes were analyzed and visualized through Pymol and BIOVIA Discovery Studio 2016 to check and compare the accurate binding of different antiviral compounds that provide a three-dimensional (3D) platform for the visualization of the results. Such technologies are developed to facilitate the study and simulation of the docked complexes in drug designing phase (Gusman & Shoemake, 2017; Yuan et al., 2017) .

The complete genome of SARS-CoV-2 was downloaded up to 30 kb in size from NCBI. The length of the sequence was enough, so we do not need to split the sequence into fragments. As for peptide mass fingerprinting, this nucleotides sequence was then forwarded for further analysis. SARS-CoV-2 sequence was translated into an amino acid sequence to accomplish the targeted goal and calculate its peptide masses. We use the EMBOSS TRANSEQ server to translate the nCOV-2019 genome sequence. For every possible outcome, we selected the whole amino acid sequence to calculate the peptide masses. The protein structure of the translated amino acid sequence is shown in Figure 2 .

The in silico based peptide mass calculation produced up to 4-5 decimals masses of peptides for all amino acids sequences based on enzyme digestion. Average monoisotopic and isotopic mass values were also given for these modifications. Peptide Mass online server is used to identify peptide masses. We have digested the amino acid sequence of SARS-CoV2 in silico with trypsin and selected some online parameters, a threshold value as the resultant peptide must be greater than 500 Daltons, peptides below this threshold may be too small to visualize in a mass spectrum, and we also allow 1 missed cleavage and then generated the masses of peptides. Peptide Mass also results in masses values of concerned protein and theoretical points. Protein Prospector was also used for cross validation. In the results, 99.7% of the sequence was covered. The estimated masses of SARS- CoV-2 peptides and overall, in silico fragmentation of the protein sequence are shown in Table 1 . We searched the MASCOT database against the peptides obtained from digestion.

The peak list is needed for Peptide Mass Fingerprint. The peak list was created by translating the raw file to peak list through peaking or peak detection. The MASCOT server is used for peptide mass fingerprinting. It is an important tool to use mass spectrometry data for peptide identification. Several other programs are similar to MASCOT, but it is unique since it integrates all the validated searching methods (Damodaran et al., 2007) . As nCOV-2019 is a viral disease, we selected the whole taxonomy of viruses to be looked for in MASCOT with cleavage enzyme trypsin and missed cleavage 1, which implies that it will allow up to 1 mutation in related peptides. The peak list was entered as a peptide mass fingerprinting data file. We picked Swissprot for the search database because it is nonredundant and fairly small, helpful for statistically meaningful matches (Bairoch and Apweiler, 2000) . In the homology search results, we found three most substantial matches by a significant threshold pvalue of less than 0.05, with the highest score of 93. Two of them match with the SARS coronavirus (Maier et al., 2015) . While the other one belongs to Pseudomonas phage B3. A brief description is shown in Table 2 .

MASCOT database identifies the viruses and proteins which contain the matched peptides sequences along with complete annotation. We screened the highest scored matched peptides, as shown in Table 3 .

As we have to predict the structures of identified peptides because the 3D structure determines their function (Stryer, n.d.). So we predicted the peptide structures for each matched peptide sequence from the de novo peptide predicting approach. PEP-FOLD 3 online server was used for this purpose (Lamiable et al., 2016) . The 3D structures of identified peptides are given in Table 4 with the peptide sequence and missed cleavages.

The identified peptide structures of SARS-COV-2 peptides were bound with a drug and a medicinal compound. Before binding, it was important to test if the compounds are valid or not. So, for this purpose, the properties of the compounds were checked by ACD/I labs and ProTox Server. Lipinski rules were identified by ACD/I labs for either less or no adverse effects (Gupta et al., 2020; Hamza et al., 2019) , and it consists of 5 properties, molecular weight should be less than 500 Da, Hydrogen bond acceptor (HBA) <¼10, Hydrogen bond donor 5, topological polar surface area (TPSA) < 140 and logP < 5 while the toxicity was predicted by the ProTox web server. This includes the details of both chemical and molecular targets. According to the Globally Harmonized System (GHS), toxicity has been classified into six classes. On the scale class VI is non-toxic, class V is moderate, class IV is Figure 3 . Druggability pocket identified for selected peptide through the PockDrug server and the interacting amino acids of the peptides are ARG25, PHE22, VAL2, VAL18, VAL19, GLY1, ILE3, and GLU21. Molecular docking is now extensively used to study the interaction between large molecule and small ligand for drug development or drug discovery. Docking is performed to determine the binding energy and the bound conformation of small molecules to the protein target (Pant et al., 2020; Seeliger & De Groot, 2010) . There are actually different methods available for the ligand docking. AutoDock 4 and AutoDock Vina are effective and manual among them. After the data was organized and interpreted, both of the above methods are freely accessible, but AutoDock Vina, due to its extra default features considered to be credible and quick (Forli et al., 2016) . Furthermore, AutoDock 4 has some limitations, AutoDock Vina helps to improve all those limitations specifically limited grid map size, rotatable bonds, and many atom numbers, it computes it by itself. As a consequence, for binding mode prediction, consequently, AutoDock Vina is more satisfactory and preferable (Trott & Olson, 2009 ). less toxic, class III is toxic, while class II and I are fatal (Hamza et al., 2019) .

All the three selected compounds fulfill the Lipinski rules and lie in the safe zone of toxicity, as shown in Table 5 .

The ability of the protein to bind a drug-like molecule with high affinity is considered as the druggability of protein. The pocket druggability of the selected peptide was predicted through the PockDrug server, providing consistent druggability results with several estimation methods (Hussein et al., 2015) . The selected peptide (GVITHDVSSAINRPQIGVVREFLTR) for docking was chosen and the pocket of peptide is shown in Figure 3 .

AutoDock Vina was used to bind the SARS-CoV-2 peptides to our chosen antiviral compounds. AutoDock Vina is an opensource and free for its users (Chang et al., 2010; Jaghoori et al., 2016; Yang & Sharp, 2006) . AutoDock Vina input requires interacting amino acid residues analysis of predicted peptide (GVITHDVSSAINRPQIGVVREFLTR) with Anthraquinone. Shows that ligand fits into the hydrophobic surface with the energy of -6.0 kcal/mol. (B) 2D interacted structure of peptide and Anthraquinone. As described above that the druggability pocket contains several amino acids (ARG25, PHE22, VAL2, VAL18, VAL19, GLY1, ILE3, and GLU21) and these interacting amino acids are correlated with the three selected compounds for docking.

Figure 7. Surface exposed selected peptide from full-length protein. In Figure 7 , the blue color shows the whole protein while yellow is the selected peptide that lies on the side/front of the protein. The molecule can easily access the peptide.

PDBQT files of both ligand and receptor while it outputs a poses list ranking by DG in kcal/mol, the binding energy. For the maximum number of poses output, the num_modes were set to 20 while the energy range to 10. The best poses were screened using RMSD values: ranging from 0 < 1.5. First of all, we prepared our peptide (GVITHDVSSAINRPQIGVVREFLTR) for docking, receptor was saved as macromolecule in the PDBQT file. Then by default, the grid options (x,y,z dimensions) to 26 and Spacing (angstrom) ¼ 1 to cover the maximum area of a peptide were set. Second, ligand compounds were prepared by adding torsions ¼ 6 and saved in the PDBQT file. In the configuration file, we selected the exhaustiveness ¼ 8 and performed further simulations of docking. The best poses obtained from molecular docking are shown in Figures 2-4 , along with interacting residues with peptides position. The energies obtained from AutoDock Vina for hydroxychloroquine was -5.1 kcal/mol, kaempferol (flavonoid) À6.2 kcal/mol, and anthraquinone -6.0 kcal/mol. Figures 2-4 shows the visualization of the drug complex, visualized through pymol and discovery studio. The drug compounds accurately fit into the hydrophobic surface of peptides that ensure the optimal attachment of drug compounds to the target peptides. In the figures, 2D structures of drug compounds shows different types of bonding with receptor molecules. It does not produce any unfavorable bumps that can affect the nature of bonding. So, from the aforementioned findings, it is confirmed that the chosen antiviral compounds are effective inhibitors against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and can help the immune system to fight against COVID-19 (Figures 5 and 6 ).

Since peptides are shorter in length and could be embedded in the full-length protein a question arises that whether the ligand compound can meet the target peptide for binding mechanism? But the surface was exposed to the chosen binding and can easily be accessed by a ligand compound successfully results in a docked complex. The selected peptide is modeled as yellow color in Figures 7 and 8. 

In this research work, the viral peptides of SARS-CoV-2 were identified through peptide mass fingerprinting technique. This approach involves the mass calculation of protein translated from the whole genome of SARS-CoV-2, these masses were searched against databases for the identification of viral peptides. Fifteen viral peptides were identified for which the 3D structures were predicted. In this study, three compounds, Hydroxychloroquine, Kaempferol, and Anthraquinone, were chosen on the basis of their antiviral properties which could bind to the target and were nontoxic. For molecular docking of viral peptides and antiviral compounds, AutoDock Vina was used for molecular docking of viral peptides and anti-viral compounds because it is more accurate and reliable than other online servers or techniques. AutoDock Vina conforms to the ligand rotational and conformational shifts and results in the optimum poses of the compounds. The chosen compounds provided strongest interaction with peptides. In future, it is suggested that these compounds should be considered and clinically tested for new effective antiviral compounds against COVID-19.

http://orcid.org/0000-0003-3224-2891

Moroccan medicinal plants as inhibitors of COVID-19: Computational investigations

In silico study the inhibition of Angiotensin converting enzyme 2 receptor of COVID-19 by Ammoides verticillata components harvested from western Algeria

Using integrated computational approaches to identify safe and rapid treatment for SARS-CoV-2

The SWISS-PROT protein sequence database and its supplement TrEMBL in 2000

SILAC and iTRAQ Quantitation on an Orbitrap Using Protein Prospector. The proceedings of 56th ASMS

Full-length protein with highlight peptides, (A) one side view (B) another side view. In Figure 8, the identified peptides are mostly surface exposed and can be easily accessible by the molecule. The highlighted yellow colors are the identified peptides

Evaluation of the antiviral activity of anthraquinones, anthrones and anthraquinone derivatives against human cytomegalovirus

Novel 2019 Coronavirus structure, mechanism of action, antiviral drug promises and rule out against its treatment

Nutritional characterization of Moringa (Moringa oleifera Lam.) leaves

A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-to-person transmission: A study of a family cluster

Virtual screening for HIV protease inhibitors: A comparison of AutoDock 4 and Vina

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: A descriptive study

Coronavirus disease 2019: In-home isolation room construction. A & A Practice

Evaluating peptide mass fingerprinting-based protein identification

An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study

ProTox: A web server for the in silico prediction of rodent oral toxicity

Novel guanosine derivatives against MERS CoV polymerase: An in silico perspective

Drug repurposing for coronavirus (COVID-19): In silico screening of known drugs against coronavirus 3CL hydrolase and protease enzymes

Reverse vaccinology approach to design a novel multi-epitope vaccine candidate against COVID-19: An in silico study

Computational protein-ligand docking and virtual drug screening with the AutoDock suite

Preparation of proteins and peptides for mass spectrometry analysis

In-silico approaches to detect inhibitors of the human severe acute respiratory syndrome coronavirus envelope protein ion channel

Evaluation and optimization of in silico designed sphingosine-1-phosphate (S1P) receptor subtype 1 modulators for the management of multiple sclerosis

Potential inhibitors of Coronavirus 3-Chymotrypsin-Like Protease (3CLpro): An in silico screening of alkaloids and terpenoids from African medicinal plants

Design and synthesis of novel inhibitor against Ser121 and Val122 mutations in P53 Cancer gene

A review on the cleavage priming of the spike protein on coronavirus by angiotensin-converting enzyme-2 and furin

Protein identification: The origins of peptide mass fingerprinting

Clinical features of patients infected with 2019 novel coronavirus in Wuhan. The Lancet

PockDrug-Server: A new web server for predicting pocket druggability on holo and apo proteins

A molecular modeling approach to identify effective antiviral phytochemicals against the main protease of SARS-CoV-2

1001 Ways to run AutoDock Vina for virtual screening

Phytochemicals and uses of Moringa oleifera leaves in Ugandan rural communities

Targeting SARS-CoV-2: A systematic drug repurposing approach to identify promising inhibitors against 3C-like proteinase and 2'-O-ribose methyltransferase

Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach

Morintides: Cargo-free chitin-binding peptides from Moringa oleifera

Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China

Understanding the binding affinity of noscapines with protease of SARS-CoV-2 for COVID-19 using MD simulations at different temperatures

Drug and vaccine design against novel Coronavirus (2019-nCoV) spike protein through computational approach

PEP-FOLD3: Faster de novo structure prediction for linear peptides in solution and in complex

Introduction to proteomics: Tools for the new biology

Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro

FDA-approved thiol-reacting drugs that potentially bind into the SARS-CoV-2 main protease, essential for viral replication

Genomic characterisation and epidemiology of 2019 novel coronavirus: Implications for virus origins and receptor binding

Coronaviruses: Methods and protocols. Coronaviruses Methods & Protocols

ACD/I-Lab 4.5: An internet service review

Mass spectrometry data analysis in proteomics

Computational studies of drug repurposing and synergism of lopinavir, oseltamivir and ritonavir binding with SARS-CoV-2 protease against COVID-19

Phytochemical, proximate and mineral composition of leaf extracts of Moringa oleifera Lam

Peptide-like and small-molecule inhibitors against Covid-19

EMBOSS: The European molecular biology open software suite

In-silico homology assisted identification of inhibitor of RNA binding against 2019-nCoV N-protein (N terminal domain)

Mechanisms of action of hydroxychloroquine and chloroquine: Implications for rheumatology

In vitro antiviral activity of the anthraquinone chrysophanic acid against poliovirus

Quantitative analyses of medicinal plants consumption among the inhabitants of Shangla-Kohistan areas in Northern-Pakistan

An in-silico evaluation of different Saikosaponins for their potency against SARS-CoV-2 using NSP15 and fusion spike glycoprotein as targets

Chapter 6, Exploring Genes

Epitope-based peptide vaccine design and target site depiction against Middle East respiratory syndrome Coronavirus: An immune-informatics study

Proteome analysis of mouse brain: Two-dimensional electrophoresis profiles of tissue proteins during the course of aging

Stilbene-based natural compounds as promising drug candidates against COVID-19

Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro

Protein identification and analysis tools in the ExPASy server

Nowcasting and forecasting the potential domestic and international spread of the 2019-nCoV outbreak originating in Wuhan, China: A modelling study

Atomic charge parameters for the finite difference Poisson-Boltzmann method using electronegativity neutralization

In vitro antiviral activity and projection of optimized dosing design of hydroxychloroquine for the treatment of severe acute respiratory syndrome Coronavirus 2 (SARS-CoV-2)

Using PyMOL as a platform for computational drug design

Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes